June 2016

Study to Assess the Taste Profile of Different ALS-008176 Oral Liquid Formulations in Healthy Adult Participants

Condition:   Healthy
Interventions:   Drug: Formulation A (ALS-008176);   Drug: Formulation B (ALS-008176);   Drug: Formulation C (ALS-008176);   Drug: Formulation D (ALS-008176);   Drug: Formulation E (ALS-008176);   Drug: Formulation F (ALS-008176);   Drug: Formulation G1 (ALS-008176);   Drug: Formulation G2 (ALS-008176);   Drug: Formulation G3 (ALS-008176);   Drug: Formulation H1 (ALS-008176);   Drug: Formulation H2 (ALS-008176);   Drug: Formulation H3 (ALS-008176)
Sponsor:   Janssen Research & Development, LLC

Former England players to feature in concussion research study

The RFU said the purpose of the study is to see what links can be established between rugby union-related head trauma and conditions such as dementia, amyotrophic lateral sclerosis, Parkinson's disease and chronic traumatic encephalopathy. Simon Kemp ...

Pages